Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

By Vanky E.  

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1734-1740

Oxford University Press

Access to resources Recommend Favorite

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

By Glueck Charles J.   Wang Ping   Goldenberg Naila   Sieve-Smith Luann  

Human Reproduction, Vol. 17, Iss. 11, 2002-11 ,pp. : 2858-2864

Oxford University Press

Access to resources Recommend Favorite

Metformin versus lifestyle changes in treating women with polycystic ovary syndrome

By Curi Daniella D.G.   Fonseca Angela Maggio   Marcondes José Antônio M.   Almeida José Alcione M.   Bagnoli Vicente R.   Soares José Maria   Baracat Edmund Chada  

Gynecological Endocrinology, Vol. 28, Iss. 3, 2012-03 ,pp. : 182-185

Informa Healthcare

Access to resources Recommend Favorite

A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome

By Mohsen Iman Abdel  

Gynecological Endocrinology, Vol. 28, Iss. 4, 2012-04 ,pp. : 269-272

Informa Healthcare

Access to resources Recommend Favorite